• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ ENTERIC BACTERIAL PANEL; GASTROINTESTINAL BACTERIAL PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ ENTERIC BACTERIAL PANEL; GASTROINTESTINAL BACTERIAL PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM Back to Search Results
Catalog Number 442963
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/31/2023
Event Type  malfunction  
Manufacturer Narrative
There were multiple medical device types.The information for each additional type is as follows: d.2.Medical device type: ooi, pch h.3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
2 of 6 it was reported that while using bd max¿ enteric bacterial panel, there were shiga toxin false positives: no patient impact reported.Id max ct ma state ph lab (elisa) l3681267241 34-35 not detected.
 
Manufacturer Narrative
H.6.Investigation summary: the complaint investigation for discrepant results when using the bd max¿ enteric bacterial panel assay (ref.442963) from lots 3137722 and 3137729 was performed by the review of the manufacturing records, review of customer¿s data and by the complaint¿s history review.Review of the manufacturing records of bd max¿ enteric bacterial panel assay indicated that lots 3137722 and 3137729 were manufactured according to specifications and met performance requirements.Customer complained about discrepant stx results and increase of stx positive rate since (b)(6) 2023 when using the bd max¿ enteric bacterial panel assay kit lots 3137722 and 3137729.Customer provided database and runs (220, 222, 223, 224 and 226) from instruments (b)(6) for investigation.Database analysis showed that the rate of stx positive results slightly increased in (b)(6) 2023.Manual pcr curve adjudication analysis of all the stx positive results found in the database, since (b)(6) 2023 revealed true positive results, without any anomaly.Most of the stx positive samples were retested using a new sample preparation (new sample buffer tube) and all gave the same result than the initial test.No discrepant result was obtained on this bd max¿ instrument.According to the complaint text and additional information received for the investigation, the discrepancies were obtained after results from several verification tests were performed using other assays (stx shiga 1 and 2 antigens, elisa, biofire gi panel pcr), were compared to the bd max¿ results.Considering that the limit of detection can vary between different assays, and based on the data provided, bd was unable to find the exact cause of the customer¿s positive results.The analysis strongly suggests true positive results and no product issue is suspected.The root cause was not identified.There is no indication of a reagent issue based on the analysis of the complaints received for discrepant results on the bd max¿ enteric bacterial panel assay lots 3137722 and 3137729.Bd cannot confirm the complaint based on the investigation that was performed.Bd quality will continue to monitor for trends.B.5:describe event: report 2 of 5.It was reported that while using bd max¿ enteric bacterial panel, there was a false positive.There was no health impact or consequences reported.B.6:relevant tests: biofire, elisa, antigen testing; d4.Medical device lot#: 3137722; d4.Medical device expiration date: 02-nov-2024; h4.Device manufacture date: 17-may-2023; e.1 initial reporter first name: (b)(6); e.1.Initial reporter last name: (b)(6).
 
Event Description
Report 2 of 5 it was reported that while using bd max¿ enteric bacterial panel, there was a false positive.There was no health impact or consequences reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAX¿ ENTERIC BACTERIAL PANEL
Type of Device
GASTROINTESTINAL BACTERIAL PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM
Manufacturer (Section D)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer (Section G)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer Contact
jo doyka
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key18274380
MDR Text Key329834762
Report Number3007420875-2023-00113
Device Sequence Number1
Product Code PCI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K140111
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/04/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/06/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number442963
Device Lot Number3137722
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/17/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-